SR ONE CAPITAL MANAGEMENT, LP CRSP Holdings History
Number of Shares
1.05 Mil
Current Holdings Value*
$35.70 Mil
% of Portfolio
9.17%
Total Estimate Gain
$-21.40 Mil
% of Total Estimate Gain
-28.50%
SR ONE CAPITAL MANAGEMENT, LP's CRISPR Therapeutics AG Holding Summary
As of 2025-03-31, SR ONE CAPITAL MANAGEMENT, LP held 1.05 Mil shares of CRISPR Therapeutics AG(CRSP), totaling $35.70 Mil. This investment constitutes 9.17% of their stock portfolio, and SR ONE CAPITAL MANAGEMENT, LP now holds 1.21% of the outstanding CRISPR Therapeutics AG(CRSP) stock.
The initial trade took place in 2024Q1. And since then SR ONE CAPITAL MANAGEMENT, LP has made 1 purchases of CRSP, at an average price of $71.59, for a total of 1.05 Mil shares. Based on historical transaction data and CRSP's current price of $51.19, SR ONE CAPITAL MANAGEMENT, LP's estimated gain on his CRSP holdings is $-21.40 Mil, reflecting a -28.50% gain to date.
SR ONE CAPITAL MANAGEMENT, LP CRSP ($51.19) Holding Chart
SR ONE CAPITAL MANAGEMENT, LP CRSP ($51.19) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1